Cargando…
Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
A small library of 36 functionalized benzophenone thiosemicarbazone analogs has been prepared by chemical synthesis and evaluated for their ability to inhibit the cysteine proteases cathepsin L and cathepsin B. Inhibitors of cathepsins L and B have the potential to limit or arrest cancer metastasis....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125537/ https://www.ncbi.nlm.nih.gov/pubmed/20089402 http://dx.doi.org/10.1016/j.bmcl.2009.12.090 |
_version_ | 1783515966894768128 |
---|---|
author | Kishore Kumar, G.D. Chavarria, Gustavo E. Charlton-Sevcik, Amanda K. Arispe, Wara M. MacDonough, Matthew T. Strecker, Tracy E. Chen, Shen-En Siim, Bronwyn G. Chaplin, David J. Trawick, Mary Lynn Pinney, Kevin G. |
author_facet | Kishore Kumar, G.D. Chavarria, Gustavo E. Charlton-Sevcik, Amanda K. Arispe, Wara M. MacDonough, Matthew T. Strecker, Tracy E. Chen, Shen-En Siim, Bronwyn G. Chaplin, David J. Trawick, Mary Lynn Pinney, Kevin G. |
author_sort | Kishore Kumar, G.D. |
collection | PubMed |
description | A small library of 36 functionalized benzophenone thiosemicarbazone analogs has been prepared by chemical synthesis and evaluated for their ability to inhibit the cysteine proteases cathepsin L and cathepsin B. Inhibitors of cathepsins L and B have the potential to limit or arrest cancer metastasis. The six most active inhibitors of cathepsin L (IC(50) < 85 nM) in this series incorporate a meta-bromo substituent in one aryl ring along with a variety of functional groups in the second aryl ring. These six analogs are selective for their inhibition of cathepsin L versus cathepsin B (IC(50) > 10,000 nM). The most active analog in the series, 3-bromophenyl-2′-fluorophenyl thiosemicarbazone 1, also efficiently inhibits cell invasion of the DU-145 human prostate cancer cell line. |
format | Online Article Text |
id | pubmed-7125537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71255372020-04-08 Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors Kishore Kumar, G.D. Chavarria, Gustavo E. Charlton-Sevcik, Amanda K. Arispe, Wara M. MacDonough, Matthew T. Strecker, Tracy E. Chen, Shen-En Siim, Bronwyn G. Chaplin, David J. Trawick, Mary Lynn Pinney, Kevin G. Bioorg Med Chem Lett Article A small library of 36 functionalized benzophenone thiosemicarbazone analogs has been prepared by chemical synthesis and evaluated for their ability to inhibit the cysteine proteases cathepsin L and cathepsin B. Inhibitors of cathepsins L and B have the potential to limit or arrest cancer metastasis. The six most active inhibitors of cathepsin L (IC(50) < 85 nM) in this series incorporate a meta-bromo substituent in one aryl ring along with a variety of functional groups in the second aryl ring. These six analogs are selective for their inhibition of cathepsin L versus cathepsin B (IC(50) > 10,000 nM). The most active analog in the series, 3-bromophenyl-2′-fluorophenyl thiosemicarbazone 1, also efficiently inhibits cell invasion of the DU-145 human prostate cancer cell line. Elsevier Ltd. 2010-02-15 2010-01-06 /pmc/articles/PMC7125537/ /pubmed/20089402 http://dx.doi.org/10.1016/j.bmcl.2009.12.090 Text en Copyright © 2010 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kishore Kumar, G.D. Chavarria, Gustavo E. Charlton-Sevcik, Amanda K. Arispe, Wara M. MacDonough, Matthew T. Strecker, Tracy E. Chen, Shen-En Siim, Bronwyn G. Chaplin, David J. Trawick, Mary Lynn Pinney, Kevin G. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title | Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title_full | Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title_fullStr | Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title_full_unstemmed | Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title_short | Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors |
title_sort | design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin l inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125537/ https://www.ncbi.nlm.nih.gov/pubmed/20089402 http://dx.doi.org/10.1016/j.bmcl.2009.12.090 |
work_keys_str_mv | AT kishorekumargd designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT chavarriagustavoe designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT charltonsevcikamandak designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT arispewaram designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT macdonoughmatthewt designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT streckertracye designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT chenshenen designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT siimbronwyng designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT chaplindavidj designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT trawickmarylynn designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors AT pinneykeving designsynthesisandbiologicalevaluationofpotentthiosemicarbazonebasedcathepsinlinhibitors |